Back to Search
MARK ELMER, M.D.
M.D.
Emergency Medicine Physician
NPI: 1245597137IndividualAccepts Medicare
Specialties, Licenses & Credentials
Emergency Medicine PhysicianPrimary
Emergency Medicine
Code: 207P00000X
267132(MA)
CMS Specialties
PrimaryEMERGENCY MEDICINE
Education
NEW YORK MEDICAL COLLEGE
Class of 2012
Research & Publications (9)
Community assembly of terrestrial testate amoebae: how is the very first beginning characterized?
PMID 17972129·Microb Ecol·2008
7-preclinical
The degradation of HFR1, a putative bHLH class transcription factor involved in light signaling, is regulated by phosphorylation and requires COP1.
PMID 15620659·Curr Biol·2004
4-observational
The oral NK(1) antagonist, aprepitant, given with standard antiemetics provides protection against nausea and vomiting over multiple cycles of cisplatin-based chemotherapy: a combined analysis of two randomised, placebo-controlled phase III clinical trials.
PMID 14746859·Eur J Cancer·2004
3-trial
Addition of the oral NK1 antagonist aprepitant to standard antiemetics provides protection against nausea and vomiting during multiple cycles of cisplatin-based chemotherapy.
PMID 14559891·J Clin Oncol·2003
3-trial
The oral neurokinin-1 antagonist aprepitant for the prevention of chemotherapy-induced nausea and vomiting: a multinational, randomized, double-blind, placebo-controlled trial in patients receiving high-dose cisplatin--the Aprepitant Protocol 052 Study Group.
PMID 14559886·J Clin Oncol·2003
3-trial
Assessing the impact of chemotherapy-induced nausea and vomiting on patients' daily lives: a modified version of the Functional Living Index-Emesis (FLIE) with 5-day recall.
PMID 12827483·Support Care Cancer·2003
3-trial
Functional relevance of antiemetic control. Experience using the FLIE questionnaire in a randomised study of the NK-1 antagonist aprepitant.
PMID 12826042·Eur J Cancer·2003
3-trial
Establishing the dose of the oral NK1 antagonist aprepitant for the prevention of chemotherapy-induced nausea and vomiting.
PMID 12712486·Cancer·2003
3-trial
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 1493 CAMBRIDGE ST
CAMBRIDGE, MA 02139 - Phone
- (617) 665-1435
Quick Facts
- NPI
- 1245597137
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Accepted
- Specialties
- 1
- Locations
- 1
- Years in Practice
- 14
- Publications
- 9
Are you this provider?
Claim Your Profile